ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis

ClinicalTrials.gov ID: NCT05848258

Public ClinicalTrials.gov record NCT05848258. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 10:35 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Adaptive Phase 2a/2b, Randomized, Double-Blind, Placebo-Controlled Study of LY3871801 in Adult Participants With Moderately-to-Severely Active Rheumatoid Arthritis

Study identification

NCT ID
NCT05848258
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
164 participants

Conditions and interventions

Interventions

  • LY3871801 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 22, 2023
Primary completion
Dec 7, 2025
Completion
Mar 31, 2026
Last update posted
Apr 22, 2026

2023 – 2026

United States locations

U.S. sites
12
U.S. states
8
U.S. cities
12
Facility City State ZIP Site status
Newport Huntington Medical Group Huntington Beach California 92648
Integrity Clinical Research Doral Florida 33122
Advanced Clinical Research of Orlando - Ocoee Ocoee Florida 34761
Encore Medical Research - Weston Weston Florida 33331
Conquest Research Winter Park Florida 32789
Willow Rheumatology and Wellness PLLC Willowbrook Illinois 60527
Accurate Clinical Research, Inc Lake Charles Louisiana 70605
Joseph S. and Diane H. Steinberg Ambulatory Care Center Brooklyn New York 11201
Icahn School of Medicine at Mount Sinai New York New York 10029
Accellacare - Salisbury Salisbury North Carolina 28144
Accurate Clinical Research, Inc Houston Texas 77089
Overlake Arthritis and Osteoporosis Center Bellevue Washington 98004

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 42 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05848258, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 22, 2026 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05848258 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →